The effect of curcumin-piperine on cardiometabolic, inflammatory and oxidative stress factors and macular vascular density in optical coherence tomography angiography (OCTA) in patients with non-proliferative diabetic retinopathy: Study protocol for a randomized, double-blind controlled trial | ||
Avicenna Journal of Phytomedicine | ||
دوره 13، شماره 2، خرداد و تیر 2023، صفحه 153-164 اصل مقاله (677.48 K) | ||
نوع مقاله: Original Research Article | ||
شناسه دیجیتال (DOI): 10.22038/ajp.2022.21512 | ||
نویسندگان | ||
Sepide Amini1؛ Amirhossein Sahebkar2؛ Alireza Dehghani3؛ Bijan Iraj4؛ Abdolreza Rezaeian-Ramsheh3؛ Gholamreza Askari1؛ Muhammed Majeed5؛ Mohammad Bagherniya* 1 | ||
1Nutrition and Food Security Research Center, Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran | ||
2Department of Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran | ||
3Ophthalmology Ward, Feiz Hospital, Isfahan University of Medical Sciences, Isfahan, Iran | ||
4Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran | ||
5Sabinsa Corporation, East Windsor, NJ, United States | ||
چکیده | ||
Objective: Curcumin is a safe phytochemical with antioxidant, anti-inflammatory, antidiabetic, and lipid-lowering effects. This study aims to investigate the efficacy of curcumin-piperine in non-proliferative diabetic retinopathy. Materials and Methods: In this double-blind randomized trial, 60 diabetic retinopathy patients after meeting the inclusion criteria will be randomly assigned to two groups of curcumin-piperine supplementation (1000 mg per day for 12 weeks) or receiving placebo. The density of small blood vessels in the retina by optical coherence tomography angiography (OCTA), fasting blood glucose, triglyceride, renal indices (blood urea nitrogen and creatinine), high-sensitivity C-reactive protein, total antioxidant capacity, total oxidant status, body mass index, waist circumference, and weight will be measured. Conclusion: If the beneficial effects of curcumin on diabetic retinopathy are observed, this safe, this natural and inexpensive herbal supplement can be considered a therapeutic solution in these patients. | ||
کلیدواژهها | ||
Diabetes mellitus؛ Curcumin؛ Piperine؛ Diabetic retinopathy؛ OCTA | ||
مراجع | ||
Adibian M, Hodaei H, Nikpayam O, Sohrab G, Hekmatdoost A, Hedayati M. 2019. The effects of curcumin supplementation on high-sensitivity c-reactive protein, serum adiponectin, and lipid profile in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. Phytother Res, 33: 1374-1383. Altobelli E, Angeletti PM, Marziliano C, Mastrodomenico M, Giuliani AR, Petrocelli R. 2021. Potential therapeutic effects of curcumin on glycemic and lipid profile in uncomplicated type 2 diabetes-a meta-analysis of randomized controlled trial. Nutrients, 13: 404. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. 2007. Bioavailability of curcumin: problems and promises. Mol Pharm, 4: 807-818. Barzegar A, Moosavi-Movahedi A. 2011. Intracellular ROS protection efficiency and free radical-scavenging activity of curcumin. PLoS One, 6: e26012. Behl T, Kaur I, Kotwani A. 2016. Implication of oxidative stress in progression of diabetic retinopathy. Surv Ophthalmol, 61: 187-196. Brownlee M. 2001. Biochemistry and molecular cell biology of diabetic complications. Nature, 414: 813-820. Carlo TED, Romano A, Waheed NK, Duker JS. 2015. A review of optical coherence tomography angiography (octa). Int J Retina Vitreous, 1: 5. Chaturvedi N, Sjoelie AK, Porta M, Aldington SJ, Fuller JH, Songini M, Kohner EM, EURODIAB Prospective Complications Study Group. 2001. Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes: the eurodiab prospective complications study. Diabetes Care, 24: 284-289. Chen FY, Zhou J, Guo N, Ma WG, Huang X, Wang H, Yuan ZY. 2015. Curcumin retunes cholesterol transport homeostasis and inflammation response in m1 macrophage to prevent atherosclerosis. Biochem Biophys Res Commun, 467: 872- 878. Choi W, Mohler KJ, Potsaid B, Lu CD, Liu JJ, Jayaraman V, Cable AE, Duker JS, Huber R, Fujimoto JG. 2013. Choriocapillaris and choroidal microvasculature imaging with ultrahigh speed oct angiography. PLoS One, 8: e81499. Antonetti DA, Klein R, Gardner TW. 2012. Diabetic retinopathy. N Engl J Med, 366, 1227-1239. El-Moselhy MA, Taye A, Sharkawi SS, El-Sisi SFI, Ahmed AF. 2011. The antihyperglycemic effect of curcumin in Amini et al. AJP, Vol. 13, No. 2, Mar-Apr 2023 162 high fat diet fed rats. Role of TNF-α and free fatty acids. Food Chem Toxicol, 49, 1129-1140. Farhood B, Mortezaee K, Hashemi-Goradel N, Khanlarkhani N, Salehi E, ShabaniNashtaei M, Najafi M, Sahebkar A. 2019. Curcumin as an anti‐ inflammatory agent: implications to radiotherapy and chemotherapy. J Cell Physiol, 234: 5728- 5740. Fingler J, Schwartz D, Yang C, Fraser SE. 2007. Mobility and transverse flow visualization using phase variance contrast with spectral domain optical coherence tomography. Opt Express, 15: 12636- 12653. Gonzalez VH, Campbell J, Holekamp NM, Kiss S, Loewenstein A, Augustin AJ, Ma J, Ho AC, Patel V, Whitcup SM. 2016. Early and long-term responses to anti– vascular endothelial growth factor therapy in diabetic macular edema: analysis of protocol data. Am J Ophthalmol, 172: 72- 79. Mahdavi- Gorabi A, Kiaie N, Hajighasemi S, Jamialahmadi T, Majeed M, Sahebkar A. 2019. The effect of curcumin on the differentiation of mesenchymal stem cells into mesodermal lineage. Molecules, 24: 4029. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. 2014. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract, 103: 137-149. Ip MS, Scott IU, Brown GC, Brown MM, Ho AC, Huang SS, Recchia FM. 2008. Anti– vascular endothelial growth factor pharmacotherapy for age-related macular degeneration: a report by the american academy of ophthalmology. Ophthalmol, 115: 1837-1846. Jacob A, Wu R, Zhou M, Wang P. 2007. Mechanism of the anti-inflammatory effect of curcumin: ppar-gamma activation. PPAR Res, 2007: 89369. Jeenger MK, Shrivastava S, Yerra VG, Naidu VGM, Ramakrishna S, Kumar A. 2015. Curcumin: A pleiotropic phytonutrient in diabetic complications. Nutr J, 31: 276- 282. Karam BS, Chavez-Moreno A, Koh W, Akar JG, Akar FG. 2017. Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes. Cardiovasc Diabetol, 16: 120. Kaur G. 2012. Amelioration of obesity, glucose intolerance, and oxidative stress in high-fat diet and low-dose streptozotocin-induced diabetic rats by combination consisting of curcumin with piperine and quercetin. ISRN Pharmacol, 2012: 957283. Kim DY, Fingler J, Zawadzki RJ, Park SS, Morse LS, Schwartz DM, Fraser SE, Werner JS. 2013. Optical imaging of the chorioretinal vasculature in the living human eye. Proc Natl Acad Sci U S A, 110: 14354-14359. Kondamudi PK, Kovelamudi H, Nayak V, Rao MC, Shenoy RR. 2015. Curcumin half analog modulates interleukin-6 and tumor necrosis factor-alpha in inflammatory bowel disease. Pharmacogn Mag, 11: S296-302. Li Y, Zhang Y, Liu DB, Liu HY, Hou WG, Dong YS. 2013. Curcumin attenuates diabetic neuropathic pain by downregulating tnf-α in a rat model. Int J Med Sci, 10: 377-381. Lontchi-Yimagou E, Sobngwi E, Tandi EM, Kengne AP. 2013. Diabetes mellitus and inflammation. Curr Diab Rep, 13: 435- 444. Mahdavi A, Moradi S, Askari G, Iraj B, Sathyapalan T, Guest PC, Bagherniya M, Sahebkar A. 2021. Effect of curcumin on glycemic control in patients with type 2 diabetes: a systematic review of randomized clinical trials. Adv Exp Med Biol, 139-149. Matsunaga D, Yi J, Puliafito CA, Kashani AH. 2014. OCT angiography in healthy human subjects. Ophthalmic Surg Lasers Imaging Retina, 45: 510-515. Mirzaei H, Shakeri A, Rashidi B, Jalili A, Banikazemi Z, Sahebkar A. 2017. Phytosomal curcumin: a review of pharmacokinetic, experimental and clinical studies. Biomed Pharmacother, 85: 102-112. Mohajeri M, Bianconi V, Ávila-Rodriguez MF, Barreto GE, Jamialahmadi T, Pirro M, Sahebkar A. 2020. Curcumin: a phytochemical modulator of estrogens and androgens in tumors of the reproductive system. Pharmacol Res, 156: 104765. Mohamed Q, Gillies MC, Wong TY. 2007. Management of diabetic retinopathy: a systematic review. JAMA, 298: 902-916. Mokgalaboni K, Ntamo Y, Ziqubu K, Curcumin-piperine and diabetic retinopathy AJP, Vol. 13, No. 2, Mar-Apr 2023 163 Nyambuya TM, Nkambule BB, Mazibuko-Mbeje SE, Gabuza KB, Chellan N, Tiano L, Dludla PV. 2021. Curcumin supplementation improves biomarkers of oxidative stress and inflammation in conditions of obesity, type 2 diabetes and nafld: updating the status of clinical evidence. Food Funct, 12: 12235-12249. Mortezaee K, Salehi E, Mirtavoos-mahyari H, Motevaseli E, Najafi M, Farhood B, Rosengren RJ, Sahebkar A. 2019. Mechanisms of apoptosis modulation by curcumin: implications for cancer therapy. J Cell Physiol, 234: 12537-12550. Nabavi SM, Marchese A, Izadi M, Curti V, Daglia M, Nabavi SF. 2015. Plants belonging to the genus thymus as antibacterial agents: from farm to pharmacy. Food Chem, 173: 339-347. Nanditha A, Ma RCW, Ramachandran A, Snehalatha C, Chan JCN, Chia KS, Shaw JE, Zimmet PZ. 2016. Diabetes in asia and the pacific: implications for the global epidemic. Diabetes Care, 39: 472-485. Neerati P, Devde R, Gangi AK. 2014. Evaluation of the effect of curcumin capsules on glyburide therapy in patients with type‐ 2 diabetes mellitus. Phytother Res, 28: 1796-1800. Nguyen QD, Brown DM, Marcus DM, Boyer DS, Patel S, Feiner L, Gibson A, Sy J, Rundle AC, Hopkins JJ. 2012. Ranibizumab for diabetic macular edema: results from 2 phase iii randomized trials: rise and ride. Ophthalmol, 119: 789-801. Nishiyama T, Mae T, Kishida H, Tsukagawa M, Mimaki Y, Kuroda M, Sashida Y, Takahashi K, Kawada T, Nakagawa K. 2005. Curcuminoids and sesquiterpenoids in turmeric (curcuma longa l.) suppress an increase in blood glucose level in type 2 diabetic kk-ay mice. Agric Food Chem 53: 959-963. Panahi Y, Kianpour P, Mohtashami R, Jafari R, Simental-Mendía LE, Sahebkar A. 2016. Curcumin lowers serum lipids and uric acid in subjects with nonalcoholic fatty liver disease: a randomized controlled trial. Cardiovasc Pharmacol, 68: 223-229. Parsamanesh N, Moossavi M, Bahrami A, Butler AE, Sahebkar A. 2018. Therapeutic potential of curcumin in diabetic complications. Pharmacol Res, 136: 181- 193. Peddada KV, Brown A, Verma V, Nebbioso M. 2019. Therapeutic potential of curcumin in major retinal pathologies. Int Ophthalmol, 39: 725-734. Peeyush KT, Gireesh G, Jobin M, Paulose CS. 2009. Neuroprotective role of curcumin in the cerebellum of streptozotocin-induced diabetic rats. Life Sci, 85: 704-710. Pivari F, Mingione A, Brasacchio C, Soldati L. 2019. Curcumin and type 2 diabetes mellitus: prevention and treatment. Nutr J, 11: 1837. Poolsup N, Suksomboon N, Kurnianta PDM, Deawjaroen K. 2019. Effects of curcumin on glycemic control and lipid profile in prediabetes and type 2 diabetes mellitus: a systematic review and meta-analysis. PLoS One, 14: e0215840. Schwartz DM, Fingler J, Kim DY, Zawadzki RJ, Morse LS, Park SS, Fraser SE, Werner JS. 2014. Phase-variance optical coherence tomography: a technique for noninvasive angiography. Ophthalmol, 121: 180-187. Seyyedebrahimi S, Khodabandehloo H, NasliEsfahani E, Meshkani R. 2018. The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebocontrolled clinical trial. Acta Diabetol, 55: 341-353. Shakeri A, Cicero AFG, Panahi Y, Mohajeri M, Sahebkar A. 2019. Curcumin: a naturally occurring autophagy modulator. Cell Physiol, 234: 5643-5654. Simó-Servat O, Hernández C, Simó R. 2019. Diabetic retinopathy in the context of patients with diabetes. Ophthalmic Res 62: 211-217. Spaide RF, Jr JMK, Cooney MJ. 2015. Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. JAMA Ophthalmol, 133: 45-50. Srinivasan K. 2005. Plant foods in the management of diabetes mellitus: spices as beneficial antidiabetic food adjuncts. Int J Food Sci Nutr, 56: 399-414. Steigerwalt R, Nebbioso M, Appendino G, Belcaro G, Ciammaichella G, Cornelli U, Luzzi R, Togni S, Dugall M, Cesarone MR, Ippolito E, Errichi BM, Ledda A, Hosoi M, Corsi M. 2012. Meriva®, a lecithinized curcumin delivery system, in diabetic microangiopathy and retinopathy. Panminerva Med, 54: 11-16. Amini et al. AJP, Vol. 13, No. 2, Mar-Apr 2023 164 Stitt AW, Curtis TM, Chen M, Medina RJ, McKay GJ, Jenkins A, Gardiner TA, Lyons TJ, Hammes TJ, Simó R, Lois N. 2016. The progress in understanding and treatment of diabetic retinopathy. Prog Retin Eye Res, 51: 156-186. Tolentino M. 2011. Systemic and ocular safety of intravitreal anti-vegf therapies for ocular neovascular disease. Surv Ophthalmol, 56: 95-113. Watal G, Dhar P, Srivastava SK, Sharma B. 2014. Herbal medicine as an alternative medicine for treating diabetes: the global burden. eCAM, 2014: 596071. Weisberg SP, Leibel R, Tortoriello DV. 2008. Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity. Endocr J, 149: 3549-3558. Yang F, Yu J, Ke F, Lan M, Li D, Tan K, Ling J, Wang Y, Wu K, Li D. 2018. Curcumin alleviates diabetic retinopathy in experimental diabetic rats. Ophthalmic Res, 60: 43-54. Yang YS, Su YF, Yang HW, Lee YH, Chou JI, Ueng KC. 2014. Lipid-lowering effects of curcumin in patients with metabolic syndrome: a randomized, double-blind, placebo-controlled trial. Phytother Res, 28: 1770-1777. Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, Zimmet P, Son HY. 2006. Epidemic obesity and type 2 diabetes in asia. Lancet, 368: 1681-1688. Zhang T, He Q, Liu Y, Chen Z, Hu H. 2021. Efficacy and safety of curcumin supplement on improvement of insulin resistance in people with type 2 diabetes mellitus: a systematic review and metaanalysis of randomized controlled trials. eCAM, 2021: 4471944. | ||
آمار تعداد مشاهده مقاله: 11,206 تعداد دریافت فایل اصل مقاله: 545 |